Literature DB >> 22877812

High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosis.

Eui-Young Choi1, Raymond T Yan, Veronica R S Fernandes, Anders Opdahl, Antoinette S Gomes, Andre L C Almeida, Colin O Wu, Kiang Liu, Jeffrey J Carr, Robyn L McClelland, David A Bluemke, Joao A C Lima.   

Abstract

BACKGROUND: Systemic inflammation has been linked to the development of heart failure in population studies including Multi-Ethnic Study of Atherosclerosis (MESA), but little evidence exists regarding potential mechanism of this relationship. In this study, we used longitudinal magnetic resonance imaging follow-up analysis to examine whether C-reactive protein (CRP) levels relate to progressive myocardial functional deterioration as a potential mechanism of incident heart failure.
METHODS: Regional myocardial functional data from MESA participants who had baseline CRP measurement and also underwent tagged cardiac magnetic resonance imaging both at baseline and at 5-year follow-up were analyzed. Left ventricular midwall and midslice peak circumferential strain (Ecc), of which a more negative value denotes stronger regional myocardial function, was measured. Circumferential strain change was calculated as the difference between baseline and follow-up Ecc.
RESULTS: During the follow-up period, participants (n = 785) with elevated CRP experienced a decrease in strain, independent of age, gender, and ethnicity (B = 0.081, ∆Ecc change per 1 mg/L CRP change, 95% CI 0.036-0.126, P < .001, model 1) and, additionally, beyond systolic blood pressure, heart rate, diabetes, smoking status, body mass index, current medication, and glomerular filtration rate (B = 0.099, 0.052-0.145, P < .001, model 2). The relationship remained statistically significant after further adjustment for left ventricular mass, coronary calcium score, and interim clinical coronary events (B = 0.098, 0.049-0.147, P < .001, model 3).
CONCLUSION: Higher CRP levels are related to progressive myocardial functional deterioration independent of subclinical atherosclerosis and clinical coronary events in asymptomatic individuals without previous history of heart disease.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877812      PMCID: PMC3417227          DOI: 10.1016/j.ahj.2012.05.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  20 in total

1.  Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI.

Authors:  J Garot; D A Bluemke; N F Osman; C E Rochitte; E R McVeigh; E A Zerhouni; J L Prince; J A Lima
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Validation of in vivo myocardial strain measurement by magnetic resonance tagging with sonomicrometry.

Authors:  S B Yeon; N Reichek; B A Tallant; J A Lima; L P Calhoun; N R Clark; E A Hoffman; K K Ho; L Axel
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

Review 3.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 4.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

5.  Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Boaz D Rosen; Mary Cushman; Khurram Nasir; David A Bluemke; Thor Edvardsen; Verônica Fernandes; Shenghan Lai; Russell P Tracy; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

Review 6.  Function of C-reactive protein.

Authors:  T W Du Clos
Journal:  Ann Med       Date:  2000-05       Impact factor: 4.709

7.  Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein.

Authors:  Subodh Verma; Shu-Hong Li; Mitesh V Badiwala; Richard D Weisel; Paul W M Fedak; Ren-Ke Li; Bikramjit Dhillon; Donald A G Mickle
Journal:  Circulation       Date:  2002-04-23       Impact factor: 29.690

8.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

9.  Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

Authors:  Eugene S Chung; Milton Packer; Kim Hung Lo; Adedigbo A Fasanmade; James T Willerson
Journal:  Circulation       Date:  2003-06-09       Impact factor: 29.690

10.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  10 in total

1.  Obesity, subclinical myocardial injury, and incident heart failure.

Authors:  Chiadi E Ndumele; Josef Coresh; Mariana Lazo; Ron C Hoogeveen; Roger S Blumenthal; Aaron R Folsom; Elizabeth Selvin; Christie M Ballantyne; Vijay Nambi
Journal:  JACC Heart Fail       Date:  2014-10-22       Impact factor: 12.035

2.  Association of pre-pregnancy subclinical insulin resistance with cardiac dysfunction in healthy nulliparous women.

Authors:  Rachel B C Psoinos; Erin A Morris; Carole A McBride; Ira M Bernstein
Journal:  Pregnancy Hypertens       Date:  2021-07-23       Impact factor: 2.899

3.  The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Miguel Cainzos-Achirica; Michael D Miedema; John W McEvoy; Mary Cushman; Zeina Dardari; Philip Greenland; Khurram Nasir; Matthew J Budoff; Mouaz H Al-Mallah; Joseph Yeboah; Roger S Blumenthal; Josep Comin-Colet; Michael J Blaha
Journal:  Int J Cardiol       Date:  2018-08-01       Impact factor: 4.164

Review 4.  New Insights from Major Prospective Cohort Studies with Cardiovascular Magnetic Resonance (CMR).

Authors:  Andrew E Arai
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  High sensitivity C-reactive protein and cardfiac resynchronization therapy in patients with advanced heart failure.

Authors:  Chi Cai; Wei Hua; Li-Gang Ding; Jing Wang; Ke-Ping Chen; Xin-Wei Yang; Zhi-Min Liu; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2014-12       Impact factor: 3.327

6.  Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD.

Authors:  Victor Nauffal; Yiyi Zhang; Tanyanan Tanawuttiwat; Elena Blasco-Colmenares; John Rickard; Joseph E Marine; Barbara Butcher; Sanaz Norgard; Timm-Michael Dickfeld; Kenneth A Ellenbogen; Eliseo Guallar; Gordon F Tomaselli; Alan Cheng
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

7.  Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation.

Authors:  Lei Zhao; Songnan Li; Chen Zhang; Jie Tian; Aijia Lu; Rong Bai; Jing An; Andreas Greiser; Jie Huang; Xiaohai Ma
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-22       Impact factor: 5.364

8.  Inter-study reproducibility of cardiovascular magnetic resonance tagging.

Authors:  Sirisha Donekal; Bharath Ambale-Venkatesh; Seth Berkowitz; Colin O Wu; Eui Young Choi; Veronica Fernandes; Raymond Yan; Ahmed A Harouni; David A Bluemke; Joao A C Lima
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-10       Impact factor: 5.364

9.  Depletion of proBNP1-108 in patients with heart failure prevents cross-reactivity with natriuretic peptides.

Authors:  François Roubille; Delphine Delseny; Jean-Paul Cristol; Delphine Merle; Nicolas Salvetat; Catherine Larue; Jean-Marc Davy; Florence Leclercq; Jean-Luc Pasquie; Luc Guerrier; Jeannette Fareh; Anne-Marie Dupuy
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

10.  Influence of atherosclerosis-related risk factors on serum high-sensitivity C-reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non-obese patients.

Authors:  Masashi Shimoda; Hideaki Kaneto; Hiroshi Yoshioka; Seizo Okauchi; Hidenori Hirukawa; Tomohiko Kimura; Yukiko Kanda-Kimura; Kenji Kohara; Shinji Kamei; Fumiko Kawasaki; Tomoatsu Mune; Kohei Kaku
Journal:  J Diabetes Investig       Date:  2015-07-27       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.